Skip to content

Kronox Lab Sciences Ltd.

Menu
  • Home
  • Company
    • About Us
    • Board of Directors
    • Board and Board Committees
    • Manufacturing Facility & Infrastructure
    • Enterprise Qualification
  • Products
    • Bulk Reagents
      • ACS Reagents
      • LR, AR & GR Reagents
    • Bulk Ingredients
      • Oral Care
      • Pharmacopoeia
      • Food & Nutraceutical
      • Personal Care & Cosmetics
      • Veterinary Pharma & Animal Health
    • Speciality Chemicals
      • Citrates
      • EDTA & Derivatives
      • Hydroxides
      • Hypophosphites
      • Heat Treatment, Quenching, Eutectic Salt
      • Phosphates
      • Speciality Anhydrous
      • Tartrates
      • Ultra High Purity Chemicals
      • Custom Specification
  • Quality
    • Quality Control & Assurance
  • Investors
    • Corporate Policies
    • IPO Documents
    • Industrial Report
    • Investor Grievance
    • Financials
    • Material Creditors
    • Annual Returns
    • Group Company
    • Newspaper Publications
    • Secretarial Compliance Report
    • Corporate Governance Report
    • Quarterly Results
    • Shareholding Pattern
    • Unclaimed Dividend
    • Subsidiary
    • Notice
    • Regu. 46 Disclosure
    • AGM
  • Career
  • Contact Us

INVESTORS

Menu
  • Corporate Policies
  • IPO Documents
  • Industrial Report
  • Investor Grievance
  • Financials
  • Material Creditors
  • Annual Returns
  • Group Company
  • Newspaper Publications
  • Secretarial Compliance Report
  • Corporate Governance Report
  • Quarterly Results
  • Shareholding Pattern
  • Unclaimed Dividend
  • Subsidiary
  • Notice
  • Regu. 46 Disclosure
  • AGM

INVESTORS

Home / Investors / Investor Grievance

DISCLOSURES UNDER REGULATION 46 OF THE LODR

1

Details of business

2

Memorandum and Articles of Association

3

Terms and conditions of appointment of independent directors

4

Composition of various committees of board of directors

5

Code of conduct of board of directors and senior management personnel

6

Details of establishment of vigil mechanism/ Whistle Blower policy

7

Criteria of making payments to non-executive directors

8

Policy on dealing with related party transactions

9

Policy for determining ‘material’ subsidiaries

10

Details of familiarization programmes imparted to independent directors

11

Contact information of the designated officials of the listed entity who are responsible for assisting and handling investor grievances

12

Email address for grievance redressal and other relevant details

13

Financial results

14

Shareholding pattern

15

Advertisements as per regulation 47(1)

16

Credit rating or revision in credit rating obtained

17

Separate audited financial statements of each subsidiary of the listed entity

18

Materiality Policy as per Regulation 30

19

Dividend Distribution policy as per Regulation 43A (as applicable)

Bulk Reagents

  • ACS Reagents
  • LR, AR & GR Reagents

Bulk Ingredients

  • Oral Care
  • Pharmacopoeia
  • Food & Nutraceutical
  • Personal Care & Cosmetics
  • Veterinary Pharma & Animal Health

Speciality Chemicals

  • Tartrates
  • Citrates
  • Hypophosphites
  • Phosphates
  • Hydroxides
  • EDTA & Derivatives
  • Ultra High Purity Chemicals
  • Custom Specification
  • Speciality Anhydrous

Contact Us

KRONOX Lab Sciences Ltd

Block No. 284, Village: Dabhasa, Taluka: Padra, Dist.: Vadodara Gujarat, INDIA- 391440

Phone: +91 – 2662 – 244077 / 244088

Email: sales@kronoxlabsciences.com info@kronoxlabsciences.com

Investor Grievance:
cs@kronoxlabsciences.com

Copyright © 2025 Kronox Lab Sciences Ltd.